B.1.1.529 variant named Omicron, designated as a Variant of concern (VOC) by WHO

WHO’s Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE) was convened on 26th November 2021 to assess the variant B.1.1.529. Based on the available evidences, the group of experts has advised WHO that this variant should be designated as a Variant of concern (VOC), and named Omicron. 

The B.1.1.529 variant was first reported to WHO from South Africa on 24th November 2021. The first known confirmed B.1.1.529 infection was from a specimen collected on 9th November 2021. Since then, the number of COVID-19 cases has steeply increased in almost all provinces in South Africa. This variant is characterised by a large number of mutations. Apparently, there is an increased risk of reinfection with this variant, as compared to others.  

Hence, based on the available evidences, the expert group has advised WHO that this variant should be designated as a VOC, and named Omicron. 

A variant of concern (VOC) is a variant of interest (VOI) that has shown an increase in transmissibility and/or virulence and/or decrease in effectiveness of public health measures at a degree of global public health significance: 

Individuals are reminded to take appropriate COVID-19 measures to reduce their risk of disease, including proven public health and social measures such as wearing well-fitting masks, hand hygiene, physical distancing, improving ventilation of indoor spaces, avoiding crowded spaces, and getting vaccinated. 

 *** 

Source:  

WHO 2021. News – Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern. Published 26 November 2021. Available online at https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern  

Latest

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both...

Future Circular Collider (FCC): CERN Council reviews Feasibility Study

The quest for the answers to the open questions (such as, which...

Chernobyl Fungi as Shield Against Cosmic Rays for Deep-Space Missions 

In 1986, the 4th unit of Chernobyl Nuclear Power Plant in Ukraine...

Myopia Control in Children: Essilor Stellest Eyeglass Lenses Authorised  

Myopia (or near-sightedness) in children is a highly prevalent...

Newsletter

Don't miss

Convalescent Plasma Therapy: An Immediate Short-Term Treatment for COVID-19

Convalescent plasma therapy holds key for the immediate treatment...

COVID-19 Not Over Yet: What We Know of the Latest Surge in China 

It is perplexing why China chose to lift zero-COVID...

Targeting Neurons in Hypothalamus for Stress-related Sleep disorders

Stress-related sleep and memory disorders are important health problem facing...

Exoplanet Science: James Webb Ushers in a New Era  

The first detection of carbon dioxide in the atmosphere...

COP28: Global stocktake reveals world is not on track to Climate goal  

The 28th Conference of the Parties (COP28) to the UN...

Climate Change: Greenhouse Gas Emissions and Air Quality are not Two Separate Problems

Climate change as a result of global warming attributed to...
SCIEU Team
SCIEU Teamhttps://www.scientificeuropean.co.uk
Scientific European® | SCIEU.com | Significant advances in science. Impact on humankind. Inspiring minds.

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such as Neuralink’s “Telepathy” implant involve establishing communication links between the brains of participants who have unmet medical needs due...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced by electric fields. Application of alternating electric fields (TTFields) to solid tumours selectively target and...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both strategic investment and active contribution in shaping its future direction.  Scientific European is an England-based media outlet providing multilingual...